Ofatumumab in Rituximab-Refractory Autoimmune Hemolytic Anemia Associated With Chronic Lymphocytic Leukemia: A Case Report and Review of Literature.

Ofatumumab in Rituximab-Refractory Autoimmune Hemolytic Anemia Associated With Chronic Lymphocytic Leukemia: A Case Report and Review of Literature. Clin Lymphoma Myeloma Leuk. 2013 May 29; Authors: Nader K, Patel M, Ferber A PMID: 23726016 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23726016?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - May 29, 2013 Category: Cancer & Oncology Authors: Nader K, Patel M, Ferber A Tags: Clin Lymphoma Myeloma Leuk Source Type: research